12 studies found for:    19097774 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Safety and Efficacy Study of KX2-391 in Patients With Bone-Metastatic, Castration-Resistant Prostate Cancer Who Have Not Received Prior Chemotherapy
Condition: Bone-Metastatic, Castration-Resistant Prostate Cancer
Intervention: Drug: KX2-391
2 Active, not recruiting Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation
Condition: Pancreatic Cancer
Intervention: Drug: Tolfenamic acid + gemcitabine + radiation
3 Completed A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC)
Conditions: Prostate Cancer;   Metastatic Castrate Resistant Prostate Cancer
Intervention: Drug: TRC105
4 Recruiting Ipilimumab and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Melanoma With Brain Metastases
Conditions: Recurrent Melanoma;   Stage IV Melanoma;   Tumors Metastatic to Brain
Interventions: Drug: Ipilimumab;   Radiation: Whole-Brain Radiation Therapy (WBRT);   Radiation: Stereotactic Radiosurgery (SRS)
5 Recruiting Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors
Condition: Metastatic Colorectal Cancer
Interventions: Procedure: Metastases Resection;   Drug: 5-Fluorouracile;   Drug: leucovorin L;   Drug: Oxaliplatin;   Drug: Irinotecan;   Drug: Cetuximab
6 Recruiting Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: gemcitabine and cisplatin (Induction chemotherapy);   Radiation: IMRT and concurrent cisplatin
7 Recruiting Radiotherapy for Oligometastatic Prostate Cancer
Condition: Oligometastatic Prostate Cancer
Intervention: Radiation: SBRT/SHRT
8 Active, not recruiting Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient
Conditions: Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer Recurrent;   No EGFR Activating Mutation
Interventions: Radiation: 18F-FLT-TEP;   Radiation: 18F-FDG-TEP
9 Active, not recruiting Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Docetaxel, cisplatin and fluorouracil;   Radiation: Concurrent chemoradiotherapy
10 Recruiting European Low and Intermediate Risk Neuroblastoma Protocol
Condition: LOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSES
Intervention: Drug: chemotherapy
11 Recruiting Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.
Condition: Metastatic Colorectal Cancer
Interventions: Procedure: Metastases resection;   Drug: Bevacizumab;   Drug: 5 FU (5Fluorouracile);   Drug: Oxaliplatine;   Drug: Irinotecan
12 Recruiting Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC Patients
Conditions: Metastatic Breast Cancer;   Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Intervention: Drug: Bevacizumab and eribulin

Indicates status has not been verified in more than two years